Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

VRDNVRDN
Showing 8 of 15 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in VIRIDIAN THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 3.1M shares of VRDN (VIRIDIAN THERAPEUTICS INC), worth $57.5M as of 2026-Q2. The position was increased (+1.6% shares). VRDN represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$57.5M

Current Shares

3.1M

Total Value Change

+$52.1M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+1.6%
$57.5M0.0%$18.37
30
2026-Q1
Increased
3.1M
+56.2%
$60.2M0.0%$29.32
42
2025-Q4
Increased
2M
+75.6%
$61.4M0.0%$31.02
45
2025-Q3
Increased
1.1M
+314.9%
$24.2M0.0%$21.61
46
2025-Q2
Increased
270,543
+8.6%
$3.8M0.0%$14.33
29
2025-Q1
Increased
249,170
+11.0%
$3.4M0.0%$14.44
29
2024-Q4
Decreased
224,484
-4.9%
$4.3M0.0%$19.54
0
2024-Q3
Decreased
235,987
-16.9%
$5.4M0.0%$23.33
0

Other major holders of VRDN: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used